Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and .
EpiPharma LLC; Cyclolab Plc.January 11, 2021 GMT
SZEGED, Hungary and BUDAPEST, Hungary, Jan. 11, 2021 (GLOBE NEWSWIRE) Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development company, today announced that the companies have signed an agreement to form a joint venture specialty pharmaceutical company to develop and commercialize novel conjugated Cyclodextrin – Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.